Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
Fish and Richardson
Daiichi Sankyo
AstraZeneca
US Army

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 5,208,041

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,208,041
Title: Essentially pure human parathyroid hormone
Abstract:Human parathyroid hormone is provided in an ultrapure form characterized by the absence of protein contaminants detectable by capillary electrophoresis analysis. A method for obtaining such ultrapure human parathyroid hormone is also described.
Inventor(s): Sindrey; Dennis R. (Etobicoke, CA)
Assignee: Allelix Biopharmaceuticals Inc. (Mississauga, CA) Glaxo Canada Inc. (Mississauga, CA)
Application Number:07/707,114
Patent Claims:see list of patent claims

Details for Patent 5,208,041

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ➤ Sign Up Allelix Biopharmaceuticals Inc. (Mississauga, CA) Glaxo Canada Inc. (Mississauga, CA) 2036-04-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ➤ Sign Up Allelix Biopharmaceuticals Inc. (Mississauga, CA) Glaxo Canada Inc. (Mississauga, CA) 2036-04-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ➤ Sign Up Allelix Biopharmaceuticals Inc. (Mississauga, CA) Glaxo Canada Inc. (Mississauga, CA) 2036-04-30 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Express Scripts
AstraZeneca
Julphar
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.